The results indicated that plasma IGF-1 concentrations in patients with OSAHS were significantly lower than those of patients in the control group (SMD=-1.13, 95%CI= -2.21–0.05, P=0.04). This evidence concerns the gene IGF1 and obstructive sleep apnea syndrome.